Dr. Charles Alden Ball is a pharmacist who is specialized in Oncology in Tuscaloosa, Alabama. Patients can reach him at 2304 2nd Ave Ne, Tuscaloosa or contact him on 205-233-1174. Active license number of Dr. Charles Alden Ball is 12649 for Oncology in Alabama. Dr. Charles Alden Ball is a licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.
Complete Profile:
Dr. Charles Alden Ball speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
Name:
Dr. Charles Alden Ball
Specialization:
Oncology
Credentials:
PHARMD
Gender:
Male
Location:
2304 2nd Ave Ne, Tuscaloosa, Alabama, 35406-1914
Phone:
205-233-1174
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Dr. Charles Alden Ball are as mentioned below.
NPI Number:
1699334243
NPI Enumeration Date:
07 Jun, 2019
NPI Last Update On:
07 Jun, 2019
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Charles Alden Ball are as mentioned below.
Specialization
License Number
State
Status
Oncology
12649
Alabama
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
2304 2nd Ave Ne, Tuscaloosa, Alabama
Zip:
35406-1914
Phone Number:
205-233-1174
Fax Number:
--
Patients can reach Dr. Charles Alden Ball at 2304 2nd Ave Ne, Tuscaloosa, Alabama or can call on phone at 205-233-1174.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 09 December, 2024.